Beta Drugs Ltd Share Price

Q: What is the share price of Beta Drugs Ltd today?

Beta Drugs Ltd share price as on 12 Jun 2026 is ₹1543.9

Pharmaceuticals

NSE: BETA Small Cap ISIN: INE351Y01019

As on 13 June 2026 at 02:32 IST

₹1,543.90

+ 67.90

(4.60%)

Sell Buy

Over 1 Month

10%

Over 6 Months

-8.86%

Over 1 Year

-17.90%

Over 3 Years

95.43%

Beta Drugs Ltd Summary

Close ₹1,476

Open ₹1,505.30

High ₹1,525.90

Low ₹1,460

Volume 8,073

Net Turnover (in Cr) ₹1.2

52Wk High -

52Wk Low -

52Wk High / Low

Beta Drugs Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,496.20

EPS (TTM) 14.14

Book Value (BV) 147.54

Div. Yield -

P/E (TTM) 104.38

Price/Book Value 10

Delivery % 41.89 %

Face Value 10

Key Ratios

PE Ratio 124.62

PB Ratio 14.91

EV to Sales 8.67

PEG Ratio -3.78

ROA 5.87

ROE 15.30

Debt-Equity 0.54

Net Profit Margin 8.51

Operating Profit Margin 17.08

Beta Drugs Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	368.79	297.07	227.87	184.59	116.62
Total Expenses	307.25	248.32	186.81	150.29	100.67
Profit Before Tax	56.97	48.75	41.06	34.30	15.95
Profit After Tax	42.42	36.44	30.72	24.83	11.72
Operating Profit After Depreciation	68.53	51.57	43.47	36.20	18.37

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	88.93	64.59	62.76	54.95	39.97
Total Non Current Assets	105.16	76.23	70.74	60.89	49.46
Total Current Assets	331.08	177.87	127.68	96.96	68.04
Total Assets	436.23	254.10	198.42	157.85	117.51
Total Shareholder's Fund	197.10	157.12	122.88	92.34	68.61

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	36.14	30.93	23.38	29.63	18.60
Net Cash Used In Investing Activities	-35.72	-13.97	-19.07	-21.75	-5.85
Net Cash Used In Financing Activities	117.97	-7.49	-2.47	-0.97	-7.71

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	226.39	199.35	158.92	125.70	80.07
Total Expenses	200.98	169.87	133.71	105.54	70.19
Profit Before Tax	20.84	29.48	25.21	20.16	9.88
Profit After Tax	15.43	21.94	18.82	14.25	6.98
Operating Profit After Depreciation	30.17	30.53	26.05	20.57	10.65

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	53.48	36.48	34.77	34.06	28.01
Total Non Current Assets	76.21	56.80	49.04	48.14	42.68
Total Current Assets	240.31	113.67	85	62.76	43.55
Total Assets	316.52	170.47	134.04	110.90	86.23
Total Shareholder's Fund	129.04	116.01	96.26	77.46	63.42

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	18.04	21.19	10.23	18.76	11.60
Net Cash Used In Investing Activities	-21.46	-11.02	-5.82	-12.72	-3.15
Net Cash Used In Financing Activities	118.20	-0.76	-2.19	1.27	-4.34

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	93.96	87.27	103.39	-	93.76
Total Expenses	76.28	70.28	82.08	-	76.42
Profit Before Tax	11.83	10.48	16.45	-	12.22
Profit After Tax	9.05	8.52	12.22	11.70	9.03
Operating Profit after Depreciation	20.57	19.30	24.30	-	21.30

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	54.35	50.28	54.48	-	53.74
Total Expenses	44.59	43.73	49.75	-	48.48
Profit Before Tax	7.07	3.38	2.12	-	2.02
Profit After Tax	5.33	3.25	1.51	4.23	1.39
Operating Profit after Depreciation	12.68	9.06	7.47	-	9.19

Beta Drugs Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,448.70

S2 1,421.40

S3 1,382.80

Pivot 1,487.30

R1 1,514.60

R2 1,553.20

R3 1,580.50

Moving Average

20 SMA 1,385.87

50 SMA 1,365.95

100 SMA 1,315

200 SMA 1,526.84

Beta Drugs Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2021 Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication (As per NSE Announcement Dated on 02/09/2021) Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2021 (As per NSE Announcement Dated on 30/09/2021) Beta Drugs Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 30, 2021 (As per NSE Announcement Dated on 05/10/2021)

AGM Date: 29 Sep 2022

Beta Drugs Limited has informed the Exchange about Notice of Annual General Meeting to be held on 29-Sep-2022 Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 22-Sep-2022 to 29-Sep-2022 for the purpose of Meeting. Beta Drugs Limited has informed the Exchange about Notice of Annual General Meeting to be held on 29-Sep-2022 (As Per NSE Announcement Dated on 05.09.2022) Beta Drugs Limited has informed the Exchange about Newspaper Advertisements (As Per NSE Announcement Dated on 06.09.2022) Beta Drugs Limited has informed the Exchange about Proceedings of Annual General Meeting held on 29-Sep-2022 (As Per NSE Announcement Dated on 29.09.2022) Beta Drugs Limited has informed the Exchange about Voting results of Annual General Meeting held on 29-Sep-2022 Beta Drugs Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 29-Sep-2022 (As Per NSE Announcement Dated on 01.10.2022) Beta Drugs Limited has informed the Exchange about Minutes of Annual General Meeting held on 29-Sep-2022 (As Per NSE Announcement Dated on 04.10.2022)

AGM Date: 30 Sep 2023

Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2023 Beta Drugs Limited has informed the Exchange with copy of minutes of Annual General Meeting held on September 30, 2023 (As Per NSE Announcement Dated on 04/10/2023)

AGM Date: 30 Sep 2024

Beta Drugs Limited has informed the Exchange regarding Board meeting held on August 31, 2024. Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2024 (As Per NSE Announcement Dated on: 30/09/2024) Beta Drugs Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 30, 2024 (As Per NSE Announcement Dated on: 01/10/2024)

AGM Date: 30 Sep 2025

Beta Drugs Limited has informed the Exchange regarding 'Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Sep-2025 to 30-Sep-2025 for the purpose of ANNUAL GENERAL MEETING to be held on 30.09.2025 Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025 (As Per NSE Announcement Dated On : 30.09.2025) Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2025. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated On : 01.10.2025)

EGM Date: 12 Nov 2024

Beta Drugs Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on November 12, 2024 Beta Drugs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on November 12, 2024 (As Per NSE Announcement Dated on: 12/11/2024) Beta Drugs Limited has informed the Exchange regarding voting results of Extraordinary General Meeting held on November 12, 2024 (As Per NSE Announcement Dated on: 13/11/2024)

EGM Date: 21 Dec 2024

Issuing a notice convening an extra-ordinary general meeting on 21st December 2024 for, inter alia, seeking shareholders' approval for inter alia matters listed out Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on December 21, 2024. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated on: 21/12/2024) Beta Drugs Limited has informed the Exchange with copy of minutes of Extraordinary General Meeting held on December 21, 2024 (As Per NSE Announcement Dated on: 27/12/2024)

EGM Date: 04 Feb 2026

Beta Drugs Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 04, 2026 (As Per NSE Announcement Dated On : 30.01.2026) Beta Drugs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 04, 2026. Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 04, 2026. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated On : 04.02.2026) Beta Drugs Limited has informed the Exchange about General Updates (As Per NSE Announcement Dated on : 16.03.2026) Beta Drugs Limited has informed the Exchange about General Updates (As Per NSE Announcement Dated on : 20.03.2026) Beta Drugs Limited has informed the Exchange about General Updates (As Per NSE Announcement Dated On : 03.04.2026)

Beta Drugs Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Beta Drugs Ltd Top Mutal Funds Invested

No data available

Beta Drugs Ltd News

Beta Drugs to conduct board meeting

On 14 May 2026

12 May 2026, 11:50 am

Beta Drugs schedules EGM

On 4 February 2026

14 Jan 2026, 09:43 am

Beta Drugs to conduct board meeting

On 9 January 2026

07 Jan 2026, 10:18 am

Beta Drugs to convene board meeting

On 6 November 2025

03 Nov 2025, 05:05 pm

Beta Drugs to hold AGM

On 30 September 2025

05 Sep 2025, 02:31 pm

Beta Drugs Ltd Stock Analysis

Annual revenue for Beta Drugs Ltd increased by 13.56% to ₹226.39 crore in FY 2025 from ₹199.35 crore in FY 2024.
Annual Net Profit for Beta Drugs Ltd decreased by 29.65% to ₹15.43 crore in FY 2025 from ₹21.94 crore in FY 2024.
Promoter Shareholding in Beta Drugs Ltd increased by 2.83% in the most recent quarter, from 64.90% in December 2025 to 66.73% in March 2026.
Beta Drugs Ltd delivered a 1-year return of -17.90% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Beta Drugs Ltd share price moved up by 4.60% from its previous close of INR ₹1,476. The latest Beta Drugs Ltd share price is INR ₹1,543.90.
Beta Drugs Ltd share price today has been at a low of 1,525 and a high of 1,584.10. Over the past 52 weeks, the Beta Drugs Ltd share price has seen a low of 990.10 and a high of 2,000.